Literature DB >> 3092891

Species specificity of lupus-like anticoagulants.

L P Clyne.   

Abstract

Mixing studies using activated partial thromboplastin time (APTT) technique were performed on 14 patients with lupus-like anticoagulants (LLACs) using human, equine, bovine, porcine and canine plasma. Eleven patients significantly prolonged the APTT of normal human plasma (patient/control ratio = greater than 1.15) but no patient inhibited bovine plasma. However, with one exception, equine APTT ratios were concordant with human ratios. Seven of fourteen patients also inhibited porcine plasma but in each case porcine APTT ratios were lower than their human or equine counterparts. None of five patients tested inhibited canine plasma. Collectively, these results suggest heterogeneity among LLACs at least with regard to species specificity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092891     DOI: 10.1007/bf00320886

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  10 in total

1.  NATURALLY OCCURRING SPECIES SPECIFIC INHIBITOR OF HUMAN PROTHROMBIN IN LUPUS ERYTHEMATOSUS.

Authors:  C HOUGIE
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

3.  Similar mechanism of various lupus anticoagulants.

Authors:  T Exner
Journal:  Thromb Haemost       Date:  1985-02-18       Impact factor: 5.249

4.  Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.

Authors:  L P Clyne; C L Honig; N Dainiak
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

5.  In vitro correction of anticoagulant activity and specific clotting factor assays in SLE.

Authors:  L P Clyne; N Dainiak; R Hoffman; J Hardin
Journal:  Thromb Res       Date:  1980-06-01       Impact factor: 3.944

6.  The lupus inhibitor: a study of its heterogeneity.

Authors:  M C Coots; M A Miller; H I Glueck
Journal:  Thromb Haemost       Date:  1981-12-23       Impact factor: 5.249

7.  The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.

Authors:  P R Kelsey; K J Stevenson; L Poller
Journal:  Thromb Haemost       Date:  1984-10-31       Impact factor: 5.249

8.  The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.

Authors:  P M Mannucci; M T Canciani; D Mari; P Meucci
Journal:  Scand J Haematol       Date:  1979-05

9.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.